| Hector Rios Optometry Llc | |
|
136 W Wichita Ave, Colwich, KS 67030-9793 | |
| (316) 796-0002 | |
| (316) 796-0006 |
| Full Name | Hector Rios Optometry Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 136 W Wichita Ave, Colwich, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518322288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1442-3 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hector Rios Optometry Llc 136 W Wichita Ave, Colwich, KS 67030-9793 Ph: (316) 796-0002 | Hector Rios Optometry Llc 136 W Wichita Ave, Colwich, KS 67030-9793 Ph: (316) 796-0002 |
News Archive
In the story of Goldilocks, a little girl tastes three different bowls of porridge to find which is not too hot, not too cold, but just the right temperature. In a study published in Advanced Therapeutics, University of Minnesota Medical School researchers report on a "Goldilocks" balance which holds the key to awakening the body's immune response to fight off brain cancer.
The University of Liverpool has been awarded £1.8m funding from the UK National Institute of Health Research to run a large study into the drug treatment of bleeding after childbirth (also called postpartum hemorrhage or PPH).
Every year, billions of dollars worth of vaccines are shipped to thousands of medical providers across the country, and every year doctors must dispose of tens of millions of dollars worth of those vaccines because they became too warm or too cold while in storage.
The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.
› Verified 2 days ago
Rios, Mason, & Associates, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 136 W Wichita Ave, Colwich, KS 67030 Phone: 316-796-0002 |